Discontinued Operations - Summary of Discontinued Operations in Consolidated Statements of Income (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Other income (expense):
Discontinued operations, net	$ 1,434,479
AxoBio [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	0	$ 4,456,816
Cost of sales	0	3,620,651
Gross profit	0	836,165
Operating expenses:
Selling and marketing	0	6,829,520
Research and development	89,972	403,616
General and administrative	470,686	2,525,715
Depreciation and amortization	636,449	1,015,894
Total operating expenses	1,197,107	10,774,745
Loss from operations	(1,197,107)	(9,938,580)
Other income (expense):
Other income	0	7
Amortization of debt discount	(4,242)	(7,070)
Inventory write-down	0	(4,754,357)
Chane in fair value of earnout liabilities	0	13,482,292
Total other (expense) income	(111,261)	8,524,040
Loss before income taxes	(1,308,368)	(1,414,540)
Income tax benefit, deferred	156,092	2,174,705
Discontinued operations, net	$ (1,152,276)	$ 760,165
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Related Party [Member] | AxoBio [Member]
Other income (expense):
Interest expense	$ (89,448)	$ (164,611)
Nonrelated Party [Member] | AxoBio [Member]
Other income (expense):
Interest expense	$ (17,571)	$ (32,221)